Chelsea Morken, PharmD

STRONG-HF aimed to study whether rapid-dose escalation of guideline-directed heart failure medications was more beneficial than usual care.

Cabotegravir showed promising results in preventing HIV transmission in men, women, and transgender women with similar rates of adverse events to oral PrEP options.

New continuous glucose monitor systems provide additional support and quality of life improvements for patients with diabetes.